Part 1, 2. Scope (2)

Q(Question)

Regarding the definition of 'sales information provision activities,' may the transmission of information related to preparation for marketing approval applications or label expansions by a clinical development division within a marketing authorization holder be considered outside the scope of the Guidelines?

A(MHLW answer)

Whether an activity constitutes a 'sales information provision activity' is assessed and determined individually based on the actual activities conducted; therefore, a purely formal judgment based on organizational unit or stated purpose alone does not automatically exclude the activity from the scope of the Guidelines.

So what (meaning): Being classified as a clinical development team or citing 'approval preparation' as the purpose does not automatically exempt an activity. The actual content of each activity must be individually assessed.

So why (rationale): Allowing exemptions based on organizational labels or stated purposes would create loopholes; the principle of assessing actual activity content was adopted to prevent circumvention.

Commentary — background, application, practical notes

The concern underlying this Q&A is how to respond to attempts to use an organizational unit's name or its formally stated purpose to escape the reach of the Guidelines. While clinical development divisions exist to secure product approvals, activities conducted during the pre-approval preparation phase may still qualify as sales information provision activities if they generate interest in a specific product among the intended audience.

A concrete example is a clinical development employee briefing physicians on interim trial results or the status of a development program before the approval application is filed. Even when this is characterized as collecting expert opinion to support the application, the practical effect on a physician who listens with future prescribing in mind can make the activity promotional in substance.

The boundary that is easily misjudged is the reasoning that 'since the product is not yet approved, this cannot yet be a promotional activity.' Even at the pre-approval stage, an activity may fall within the Guidelines if it functionally operates as one conducted with an expectation of promoting sales. A formal organizational label or stated purpose cannot justify an exemption; the content, manner, and effect on the recipient of each activity must be individually assessed.

Source: MHLW MSA Guidelines Q&A Part 1, Feb 20 2019, Q3